These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A; Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759 [TBL] [Abstract][Full Text] [Related]
24. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Singh N; Avery RK; Munoz P; Pruett TL; Alexander B; Jacobs R; Tollemar JG; Dominguez EA; Yu CM; Paterson DL; Husain S; Kusne S; Linden P Clin Infect Dis; 2003 Jan; 36(1):46-52. PubMed ID: 12491201 [TBL] [Abstract][Full Text] [Related]
25. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Kontoyiannis DP; Chamilos G; Lewis RE; Giralt S; Cortes J; Raad II; Manning JT; Han X Cancer; 2007 Sep; 110(6):1303-6. PubMed ID: 17614303 [TBL] [Abstract][Full Text] [Related]
26. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections. Mohammad RA; Klein KC Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653 [TBL] [Abstract][Full Text] [Related]
27. Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B. Linden PK; Coley K; Fontes P; Fung JJ; Kusne S Clin Infect Dis; 2003 Jul; 37(1):17-25. PubMed ID: 12830404 [TBL] [Abstract][Full Text] [Related]
29. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes. Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118 [TBL] [Abstract][Full Text] [Related]
30. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Mihu CN; King E; Yossepovitch O; Taur Y; Jakubowski A; Pamer E; Papanicolaou GA Transpl Infect Dis; 2008 Jun; 10(3):162-7. PubMed ID: 17662036 [TBL] [Abstract][Full Text] [Related]
31. Clustering of invasive Aspergillus ustus eye infections in a tertiary care hospital: a molecular epidemiologic study of an uncommon species. Saracli MA; Mutlu FM; Yildiran ST; Kurekci AE; Gonlum A; Uysal Y; Erdem U; Basustaoglu AC; Sutton DA Med Mycol; 2007 Jun; 45(4):377-84. PubMed ID: 17510862 [TBL] [Abstract][Full Text] [Related]
32. Invasive aspergillosis in a tertiary-care hospital in Thailand. Kiertiburanakul S; Thibbadee C; Santanirand P J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043 [TBL] [Abstract][Full Text] [Related]
33. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Ergin F; Arslan H; Azap A; Demirhan B; Karakayali H; Haberal M Transpl Int; 2003 Apr; 16(4):280-6. PubMed ID: 12730810 [TBL] [Abstract][Full Text] [Related]
34. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
35. Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia. Halliday C; Hoile R; Sorrell T; James G; Yadav S; Shaw P; Bleakley M; Bradstock K; Chen S Br J Haematol; 2006 Feb; 132(4):478-86. PubMed ID: 16412020 [TBL] [Abstract][Full Text] [Related]
36. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Gil L; Kozlowska-Skrzypczak M; Mol A; Poplawski D; Styczynski J; Komarnicki M Bone Marrow Transplant; 2009 Jan; 43(2):121-6. PubMed ID: 18794866 [TBL] [Abstract][Full Text] [Related]
37. Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Bénet T; Nicolle MC; Thiebaut A; Piens MA; Nicolini FE; Thomas X; Picot S; Michallet M; Vanhems P Clin Infect Dis; 2007 Sep; 45(6):682-6. PubMed ID: 17712750 [TBL] [Abstract][Full Text] [Related]